Dare Bioscience, Inc. (DARE) vs GT Biopharma, Inc. (GTBP)
- Dare Bioscience, Inc. DARE 0.72 −2.70%
- GT Biopharma, Inc. GTBP 7.03 −4.48%
Dare Bioscience, Inc. and GT Biopharma, Inc. are both Biotechnology companies. Dare Bioscience, Inc. and GT Biopharma, Inc. are of similar size ($15.2M and $14.6M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −76.2%. GT Biopharma, Inc. has the higher net margin (0.00% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Dare Bioscience, Inc. leads on 9 and GT Biopharma, Inc. on 6.
Valuation
Profitability
| Metric | DARE | GTBP | Biotechnology median |
|---|---|---|---|
| Gross margin | 58.84% | 41.67% | 65.16% |
| Operating margin | (813.35%) | 0.00% | 0.00% |
| Net margin | (804.33%) | 0.00% | 0.00% |
| Free cash flow margin | (849.36%) | 0.00% | 0.00% |
| Return on equity | 165.29% | 102.03% | (56.36%) |
| Return on assets | (62.16%) | (176.27%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack